TrivarX (ASX:TRI) Cash-to-Debt : 4.15 (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is TrivarX Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. TrivarX's cash to debt ratio for the quarter that ended in Dec. 2024 was 4.15.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, TrivarX could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for TrivarX's Cash-to-Debt or its related term are showing as below:

ASX:TRI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.24 Med: 12.51 Max: 125.97
Current: 4.15

During the past 13 years, TrivarX's highest Cash to Debt Ratio was 125.97. The lowest was 0.24. And the median was 12.51.

ASX:TRI's Cash-to-Debt is ranked better than
73.95% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 0.735 vs ASX:TRI: 4.15

TrivarX Cash-to-Debt Historical Data

The historical data trend for TrivarX's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

TrivarX Cash-to-Debt Chart

TrivarX Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Cash-to-Debt

Get a 7-Day Free Trial

10.56

92.48

15.65

2.06

53.00

TrivarX Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial															14.46	2.06	5.10	53.00	4.15

Competitive Comparison of TrivarX's Cash-to-Debt

For the Health Information Services subindustry, TrivarX's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TrivarX's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where TrivarX's Cash-to-Debt falls into.

TrivarX Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

TrivarX's Cash to Debt Ratio for the fiscal year that ended in Jun. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.848	/	(0.016	+	0)
	=	53.00

TrivarX's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.809	/	(0.035	+	0.16)
	=	4.15

TrivarX (ASX:TRI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

TrivarX Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of TrivarX's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

TrivarX Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (ASX:TRI) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

MDBIF:USA

Address

647 Beaufort Street, Mount Lawley, WA, AUS, 6050

Website

https://www.trivarx.com

TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.